Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
The ACES Study for Aseptic Pleural Effusion
NCT06210685 · View on ClinicalTrials.gov ↗
Study Summary
The study will enroll recurrent aseptic pleural effusion patients who are designated by their physician as needing treatment to control the fluid. Baseline assessment will include a history and physical, chest imaging and quality of life questionnaires. After ACES implantation, patients will remain under hospital care for general observation as per standard-of-care before being discharged home with access to electronic diaries for tracking pain and dyspnea.
Conditions Studied
Interventions
- DEVICE Automatic Continuous Effusion Shunt implantation
Study Locations (4)
Florida
- Memorial Healthcare System — Hollywood
Maryland
- Johns Hopkins School of Medicine — Baltimore
North Carolina
- University of North Carolina Pulmonary and Critical Care Medicine — Chapel Hill
Tennessee
- Vanderbilt University Medical Center — Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2024-05-12 |
| Est. Completion | 2025-12 |
| Phase | NA |
Interested in This Trial?
Always speak with your doctor before enrolling in a clinical trial.
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06210685
The ClinicalTrials.gov registry entry for NCT06210685 describes a study currently listed as active not recruiting. It is categorized as NA, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pleural Dynamics, which has 1 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.
The record links to 1 condition, with Pleural Effusion appearing as the primary indexed condition, and to 1 intervention — of which Automatic Continuous Effusion Shunt implantation is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.
Geographic footprint matters for practical reasons: NCT06210685 reports 4 study locations spanning 4 distinct geographic areas — top geographies include Florida, Maryland, North Carolina. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.
Frequently Asked Questions
What is clinical trial NCT06210685 about?
NCT06210685 is a clinical study titled "The ACES Study for Aseptic Pleural Effusion". The study will enroll recurrent aseptic pleural effusion patients who are designated by their physician as needing treatment to control the fluid. Baseline assessment will include a history and physical, chest imaging and quality of life questionnaires. After ACES implantation, patients will remain...
What is the current status of trial NCT06210685?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 25 participants. The study started on 2024-05-12. Estimated completion is 2025-12.
What conditions does trial NCT06210685 study?
This clinical trial studies the following conditions: Pleural Effusion. These conditions were identified from the trial registry and reflect the primary focus areas of the research.
What interventions are being tested in trial NCT06210685?
The interventions under investigation include: Automatic Continuous Effusion Shunt implantation (DEVICE). Each intervention is being evaluated for safety and efficacy as part of this clinical study.
Who is sponsoring clinical trial NCT06210685?
This trial is sponsored by Pleural Dynamics, which has 1 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.
Where is trial NCT06210685 being conducted?
This trial has 4 study locations across Florida, Maryland, North Carolina, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How Clinical Trials Work
Understand phases 1-4, trial design, randomization, and the informed consent process.
Patient Rights in Clinical Trials
Your rights as a participant: consent, withdrawal, privacy, and who to contact.
Finding the Right Clinical Trial
A practical guide to searching trials, understanding eligibility, and evaluating options.
All Guides
Browse our complete library of clinical trial educational resources.
Read our methodology — how this data is sourced, computed, and verified.